HomeSPRO • NASDAQ
add
Spero Therapeutics Inc
Previous close
$2.45
Day range
$2.38 - $2.45
Year range
$0.51 - $3.22
Market cap
140.72M USD
Avg Volume
328.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 41.30M | 174.51% |
Operating expense | 4.30M | -39.06% |
Net income | 31.52M | 250.90% |
Net profit margin | 76.33 | 154.97% |
Earnings per share | — | — |
EBITDA | 31.41M | 250.64% |
Effective tax rate | 0.82% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.26M | -23.87% |
Total assets | 68.92M | -37.65% |
Total liabilities | 9.90M | -84.64% |
Total equity | 59.02M | — |
Shares outstanding | 57.89M | — |
Price to book | 2.33 | — |
Return on assets | 127.57% | — |
Return on capital | 171.12% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 31.52M | 250.90% |
Cash from operations | -8.35M | 64.31% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -8.35M | 64.31% |
Free cash flow | -7.52M | 29.13% |
About
Founded
2013
Website
Employees
32
